Past and present FDA adcomm members weigh in on potential reforms

A ma­jor­i­ty of for­mer and cur­rent FDA ad­vi­so­ry com­mit­tee mem­bers sur­veyed in Ju­ly sup­port­ed re­mote par­tic­i­pa­tion in meet­ings and bet­ter com­mu­ni­ca­tion, as the FDA con­sid­ers …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.